Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Condition: Type 1 Diabetes Intervention: Drug: Insulin Glargine 300 UNT/ML [Toujeo] Sponsors: prof dr Pieter Gillard; University Hospital, Antwerp; Onze Lieve Vrouw Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2021 Category: Research Source Type: clinical trials